Effect of the triphenylphosphonium cation on the biological properties of new rhenium and technetium-99m fac-[M(CO)3(NSN)]±-type complexes: Synthesis, structural characterization, in vitro and in vivo studies
摘要:
Triphenylphosphonium (TPP) cations have been used for the development of tumor or myocardial diagnostic radiopharmaceuticals. In this work, the development of new [Tc-99m][Tc(CO)(3)(N,S,N)](+) complexes of the (N,S,N) tridentate chelator benzimidazol-2-yl-methylthioethylamine (L), and its triphenylphosphonium (TPP) cation derivative L-TPP is described. The TPP-moiety was conjugated at the N-tau-benzimidazol position of L. The reaction of the chelators L and L-TPP with a suitable precursor [Re(sol)(3)(CO)(3)](+) yielded single products of ReL+ and ReL-TPP2+. The complexes were characterized by spectroscopic methods and furthermore the structure of ReL was elucidated by X-ray crystallography. The respective Tc-99m-radiotracers were synthesized in high yield, their lipophilicity was measured and both exhibited high stability in cysteine, histidine solutions as well as in rat plasma. The in vitro cell studies in human erythroleukemia K-562 and glioblastoma U-87MG tumor cells showed that the tracer (TcL+)-Tc-99m exhibited significantly higher cellular uptake, while (TcL)-Tc-99m-TPP2+ exhibited sig-nificantly higher mitochondrial accumulation. The tracers (TcL+)-Tc-99m and 99mTcL-TPP2+ exhibited fast blood elimination and excretion via the hepatobiliary and the renal routes after intravenous administration in healthy mice. Tracer (TcL+)-Tc-99m exhibited higher myocardial uptake and renal excretion, while (TcL)-Tc-99m-TPP2+ exhibited primarily hepatobiliary excretion. These data confirm the high mitochondrial accumulation of (TcL)-Tc-99m-TPP2+ in vitro and show its potential as a candidate for tumor imaging.
Pharmacologically active thiourea and urea compounds
申请人:Smith Kline & French Laboratories Limited
公开号:US03950353A1
公开(公告)日:1976-04-13
The compounds are substituted thioalkyl-, aminoalkyl- and oxyalkyl-thioureas and ureas which are inhibitors of histamine activity.
这些化合物是取代的硫代烷基、氨基烷基和氧烷基硫脲和脲,它们是组胺活性的抑制剂。
Copper(I) complexes with ligand systems containing nitrogen and sulphur donor atoms. Spectroscopy and electrochemistry of the copper(II)/copper(I) couple
of copper(I) complexes with imine ligands resulting from the condensation of 3-formyl-1-phenyl-2-(1H)-pyridinethione with aminoalkylthioalkylbenzimidazoles has been synthesized and spectroscopically characterized. The redox propensity of the present copper(I) complexes, investigated by electrochemical techniques, confirms the relatively difficult access to the corresponding copper(II) complexes, as
Electrochemical synthesis of zinc(II), cadmium(II), and nickel(II) complexes of tetradentate Schiff-base ligands derived from aminothioether imidazoles
作者:Rufina Bastida、Teresa Lage、Conception Parrado、Teresa Rodriguez、Antonio Sousa、David E. Fenton
DOI:10.1039/dt9900002101
日期:——
The electrochemical synthesis and physicochemicalproperties of neutral zinc(II), cadmium(II), and nickel(II) complexes of Schiffbases derived from aminothioether imidazoles and substituted salicylaldehydes are reported.
Synthese positiv inotroper Substanzen: Imidazolylpropylguanidine mit Pyridin-Partialstruktur
作者:Armin Buschauer
DOI:10.1002/ardp.19883210709
日期:——
Durch zweifache Aminolyse von N‐Benzoyl‐diphenylimidocarbonat und anschließende saure Hydrolyse wurden unsymmetrisch substituierte Imidazolylpropylguanidine hergestellt. Die Substanzen wirken am H2‐Rezeptor des Atriums und am Papillarmuskel des Meerschweinchens bis zu 20mal stärker agonistisch als Histamin.
Durch zweifache Aminolyse von N-Benzoyl-diphenylimidocarbonat und anschließende saure Hydrolyse wurden unsymmetrisch substituierte Imidazolylpropylguanidine hergestellt。Die Substanzen wirken am H2-Rezeptor des Atriums und am Papilmuskel des Meerschweinchens bis zu 20mal stärker agonistisch als Histamin。
Pharmacologically active guanidine compounds in compositions and methods
申请人:Smith Kline & French Laboratories Limited
公开号:US04154844A1
公开(公告)日:1979-05-15
The compounds are substituted thioalkyl-, aminoalkyl- and oxyalkyl-guanidines which are inhibitors of histamine activity.